期刊文献+

小剂量阿司匹林治疗高龄稳定型心绞痛的有效性及安全性分析

Analysis of effectiveness and safety of low dose Aspirin in the treatment of elderly patients with stable angina pectoris
下载PDF
导出
摘要 目的分析高龄稳定型心绞痛患者口服小剂量阿司匹林治疗的临床效果及安全性。方法对比120例长期口服75 mg、100 mg阿司匹林稳定型心绞痛患者消化道出血事件及急性冠脉综合征发生率,分析有效性及安全性。结果小剂量组与常规剂量组比较,急性冠脉综合征、猝死等发生率相当,消化道出血事件减少,差异均有统计学意义(P<0.05)。结论小剂量阿司匹林治疗高龄稳定型心绞痛,其有效性与常规剂量相当,出血并发症减少,值得临床推广。 Objective To evaluate the efficacy and safety of low dose aspirin in elderly patients with stable angina pectoris, Methods To compare the incidence of acute coronary syndrome and gastrointestinal bleeding in 120 patients with long-term oral 75mg and 100mg aspirin,and to analyze the effectiveness and safety. Results Compared with the conventional dose group, the incidence of acute coronary syndrome, sudden death and other incidence of acute coronary syndrome, the incidence of gastrointestinal bleeding decreased. Conclusion Low dose aspirin in the treatment of stable angina pectoris, its effectiveness is comparable with the conventional dose, reduce bleeding complications, it is worthv of clinical annlication.
作者 史晓宁 张剑 刘东梅 乔红刚 Shi Xiaoning Zhang Jian Liu Dongmei et al.(The First People ~s Hospital of Yangquan City, Yangquan Shanxi 045000 The First Hospital of Yuilin City,The second Affiliated Hospital of Yanan University,Yulin, Shaanxi 719000)
出处 《基层医学论坛》 2017年第5期516-517,共2页 The Medical Forum
关键词 稳定型心绞痛 高龄患者 小剂量阿司匹林 疗效 安全性 Stable angina pectoris Elderly Low dose Aspirin Curative effect Safety
  • 相关文献

参考文献3

二级参考文献69

  • 1郝卫军,司全金,李小鹰.老年心血管疾病患者应用不同剂量阿司匹林抗血小板治疗的临床研究[J].中国临床保健杂志,2006,9(3):210-212. 被引量:4
  • 2孙武,岳永焕,孙彩艳.心内科门诊使用阿司匹林情况的调查[J].中国基层医药,2007,14(6):1022-1023. 被引量:1
  • 3Antithrombotic Trialists′ Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients[J].BMJ,2002,324(7329):71-86.
  • 4The SALT Collaborate Group.Swedish Aspirin Low-dose Trial(SALT)of 75mg Aspirin as secondary prophylaxis after cerebrovascular ischemic events[J].Lancet,1991,338(8779):1345 -1491.
  • 5Patrono C,Coller B,FitzGerald GA,et al.Plaelet-active Drugs:The relationships Among Dose,Effectiveness,and Side Effect.The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J].Chest,2004,126suppl3:234-264.
  • 6Krasopoulos G,Brister SJ,Beattie WS,et al.Aspirin "resistance" and risk of cardiovascular morbidity:systematic review and meta-analysis[J].BMJ,2008,336(7637):195-198.
  • 7Michelson AD,Frelinger AL III,Furman MI.Current options in platelet function testing[J].Am J Cardiol,2006,98(10A):4-10.
  • 8Michelson AD.Flow cytometry assessment of glycoprotein movements in Platelets[J].Platelets,1997,8(2):105-115.
  • 9Abrams C,Shattil SJ.Immunological detection of activation platelets in clinical disorder[J].Thromb Haemost,1991,65(5):467-650.
  • 10Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.

共引文献2072

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部